The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zinforo



Pfizer Ireland PharmaceuticalsEU/1/12/785/001

Main Information

Trade NameZinforo
Active SubstancesCeftaroline fosamil
Dosage FormPowder for concentrate for solution for infusion
Licence HolderPfizer Ireland Pharmaceuticals
Licence NumberEU/1/12/785/001

Group Information

ATC CodeJ01DI Other cephalosporins and penems
J01DI02 ceftaroline fosamil

Status

License statusAuthorised
Licence Issued23/08/2012
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back